Oncostatin M-specific receptor expression and function in regulating cell proliferation of normal and malignant mammary epithelial cells

Cytokine

Volumn 10, Issue 4, 1998, Pages 295-302

  Liu, Jingwen ^a,e   Hadjokas, Nicholas ^a   Mosley, Brace ^b   Estrov, Zeev ^c   Spence, Michael J ^a   Vestal, Robert E ^a,d  

^a St Luke's Mountain States Tumor Institute   (United States)

^b AMGEN INC   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

Cell proliferation; Cytokine receptors; gp130; Leukaemia inhibitor factor; Oncostatin M

Indexed keywords

CYTOKINE RECEPTOR; DNA; GLYCOPROTEIN GP 130; MESSENGER RNA; MONOCLONAL ANTIBODY; ONCOSTATIN M; RECEPTOR SUBTYPE;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DOSE RESPONSE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032055913     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1997.0283     Document Type: Article

References (31)

1. 1. Zarling JM, Shoyab M, Marquardt H, Hanson MB, Lioubin MN, Todaro GJ (1986) Oncostatin M: A growth regulator produced by differentiated lymphoma cells. Proc Natl Acad Sci USA 83:9739-9743.
2. 2. Brown TJ, Lioubin M, Marquardt H (1987) Purification and characterization of cytostatic lymphokines produced by activated human T-lymphocytes: synergistic antiproliferative activity of transforming growth factor β1, interferon gamma, and oncostatin M for human melanOSMa cells. J Immunol 139:2977-2983.
3. 3. Grove RI, Mazzucco C, Allegretto N, Kiener PA, Spitalny G, Radka SF, Shoyab M, Antonaccio M, Warr GA (1991) Macrophage-derived factors increase low-density lipoprotein uptake and receptor number in cultured human liver cells. J Lipid Res 32:1889-1897.
4. 4. Rose T, Bruce AG (1991) Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony stimulating factor, and interleukin 6. Proc Natl Acad Sci USA 88:8641-8645.
5. 5. Bazan F (1991) Neuropoietic cytokines in the hematopoietic fold. Neuron 7:197-208.
6. 6. Ip NY, Nye S, Boulton TG, Davis S, Taga T, Li Y, Birren SJ, Yasukawa K, Kshimoto T, Anderson DJ, Stahi N, Yancopoulos D (1992) CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducer receptor component gp130. Cell 69:1121-1132.
7. 7. Pennica. (1992) Cariotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex. J Biol Chem 270:10915-10922.
8. 8. Thomas B, Bird TA, Friend DJ, Gearing DP, Dower SK (1994) Oncostatin M and leukemia inhibitory factor trigger overlapping and different signals through partially shared receptor complexes. J Biol Chem 269;6215-6222.
9. 9. Gearing DP, Cosman, MR, Friend DJ, Gimpel S, Thut CJ, McGourty J, Brasher KK, Kinh JA, Gillis S, Mosley B, Ziegler SF, Cosman D (1992) The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Science. 255:1434-1437.
10. 10. Gearing DP, Bruce AG (1991) Oncostatin M binds the high-affinity leukemia inhibitory factor. New Biol 4:61-65.
11. 11. Bruce AG, Hoggatt IH, Rose TM (1992) Oncostatin M is a differentiation factor for myeloid leukemia cells. J Immunol 149:1271-1275.
12. 12. Liu J, Clegg HC, Shoyab M (1992) Regulation of EGR-1, c-jun, and c-myc gene expression by oncostatin M. Cell Growth Differentiation 3:307-313.
13. 13. Richard CD, Brown TJ, Shoyab M, Bauman H, Gauldie J (1992) Recombinant oncostatin M stimulates the production of acute phase protein in HepG2 cells and rat primary hepatocytes in vitro. J Immunol 148:1731-1736.
14. 14. Liu J, Modrell B, Aruffo A, Marken JS, Taga T, Yasukawa K, Murakami M, Kishimoto T, Shoyab M (1992) Interleukin-6 signal transducer gp130 mediates oncostatin M signaling. J Biol Chem 267:16763-16766.
15. 15. Liu J, Modrell B, Aroffo A, Scharnowske S, Shoyab M (1994) Interactions between oncostatin M and the IL-6 signal transducer, gp130. Cytokine 6:272-278.
16. 16. Mosley B, Imus CD, Friend D, Boian N, Thoma B, Park L, Cosman D (1996) Dual oncostatin M (OSM) receptors: cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J Biol Chem 271: 32635-32643.
17. 17. Horn D, Fitzpatrick WC, Gompper PT, Ochs V, Bolton-Hansen M, Zarling JM, Malik N, Todaro GJ, Linsley PS (1990) Regulation of cell growth by recombinant oncostatin M. Growth Factors. 2:157-165.
18. 18. Grove RI, Eberhardt C, Abid S, Mazzucco C, Liu J, Todaro G, Kiener P, Shoyab M (1993) Oncostatin M is a mitogen for rabbit vascular smooth muscle cells. Proc Natl Acad Sci USA 90:823-827.
19. 19. Zhang XG, Gu JJ, Lu ZY, Yasukawa K, Yancopoulos GD, Turner K, Shoyab M, Taga T, Kishimoto T, Bataille R, Klein B (1994) Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130. J Exp Med 179:1343-1347.
20. 20. Miles SA, Martinez-Maza O, Rezai A, Magpantay L, Kishimoto T, Nakamura S, Radka SF, Linsley PS (1992) Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells. Science 255:1432-1434.
21. 21. Nair BC, DeVico AL, Nakamura S, Copeland TD, Chen Y, Patel A, O'Nell T, Oroszlan S, Gallo RC, Sarngadharan MG (1992) Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M. Science 255:1430-1432.
22. 22. Liu J, Wallace PM, Forcier K, Hellström I, Vestal RE (1997) Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth, antagonism of growth factors, and down regulation of c-myc protooncogene. Cell Growth Differentiation 8:667-676.
23. 23. Spence M, Vestal RE, Liu J (1997) Suppression of c-myc proto oncogene by oncostatin M in breast cancer cells. Cancer Res 57:2223-2228.
24. 24. Malik N, Graves D, Shoyab M, Purchio AF (1992) Amplification and expression of heterologous oncostatin M in Chinese hamster ovary cells. DNA. Cell Biol 11:453-459.
25. 25. Current Protocols in Immunology, Chapter 5, unit 5.2: Comparison of relative signal to noise values.
26. 26. Estrov Z, Samal B, Lapushin R, Kellokumpu-Lehtinen P, Sahin AA, Kurzrock R, Talpaz M, Aggarwal BB (1995) Leukemia inhibitory factor binds to human breast cancer cells and stimulates their proliferation. J Interferon Cytokine Res 15: 905-913.
27. 27. Dhingra K, Sahin A, Emami K, Estrov Z: Leukemia inhibitory factor and its receptor in breast cancer: A potential autocrine/paracrine growth regulatory mechanism. Submitted.
28. 28. Bugno ML, Graeve P, Gatsios A, Koj PC, Heinrich JT, Kordula T (1995) Identification of the interleukin-6/oncostatin M response element in the rat tissue inhibitor of metalloproteinases-1 (TIMP-1) promoter. Nucleic Acids Res 23:5041-5047.
29. 29. Zhang L, Chang CJ, Bacus SS, Hung MC (1995) Suppressed transformation and induced differentiation of HER-2/ neuoverexpressing breast cancer cells by emodin. Cancer Res 55: 3890-3896.
30. 30. Bacus SS, Kiguchi K, Chin D, King CR, Huberman E (1990) Differentiation of cultured human breast cancer cells (AU-565 and MCF-7) associated with loss of cell surface HER/neu antigen. Mol Carcinogen 3:350-352.
31. 31. Lai L, Kadory S, Siraj AK, Lennard TWJ (1994) Oncostatin M, interleukin 2, interleukin 6 and interleukin 8 in breast cyst fluid. Int J Cancer 59:369-372.